Characteristics of Study Participants
| Characteristic | n (%) |
|---|---|
| Demographic | |
| Gender | |
| Male | 31 (75.6) |
| Female | 10 (24.4) |
| Employment status at the time of interview | |
| Employed | 12 (29.3) |
| Unemployed | 11 (26.8) |
| Retired | 1 (2.4) |
| On disability pension | 16 (39.0) |
| No data | 1 (2.4) |
| Substance use | |
| Years of benzodiazepine use | |
| <5 | 14 (34.1) |
| 5–9 | 12 (29.3) |
| >10 | 14 (34.1) |
| Not available | 1 (2.4) |
| Age at first benzodiazepine use, years | |
| <25 | 15 (36.6) |
| 25–39 | 18 (43.9) |
| >40 | 7 (17.1) |
| Could not recall | 1 (2.4) |
| Maximum dosage of benzodiazepines as diazepam equivalents, mg | |
| <50 | 14 (34.1) |
| 50–99 | 14 (34.1) |
| >100 | 13 (31.7) |
| Number of additional substances used | |
| 0 | 4 (9.8) |
| 1 | 8 (19.5) |
| >1 | 29 (70.7) |
| Comorbid psychiatric disorders | |
| Number of comorbid psychiatric diagnosis groups except SUD (F2, F3, F4, F6, F9) | |
| 0 | 10 (24.4) |
| 1 | 15 (36.6) |
| >1 | 16 (39.0) |
| Comorbid psychiatric diagnosis groups except SUD | |
| F2: Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders | 1 (2.4) |
| F3: Mood [affective] disorders | 21 (51.2) |
| F4: Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders | 12 (29.3) |
| F6: Disorders of adult personality and behavior | 14 (34.1) |
| F9: Behavioral and emotional disorders with onset usually occurring in childhood and adolescence (e.g. ADHD) | 1 (2.4) |
| Anterograde amnesia | |
| Present | 25 (61.0) |
| Absent | 14 (34.1) |
| No data | 2 (4.9) |
| Most commonly associated benzodiazepine (n = 25) | |
| Flunitrazepam | 2 (8) |
| (With alcohol) | 1 (4) |
| Midazolam | 7 (28) |
| (With alcohol) | 3 (12) |
| Oxazepam | 1 (4) |
| Unavailable/other combination | 11 (44) |
| Delinquency associated with anterograde amnesia (n = 25) | |
| Yes | 15 (60) |
| No | 5 (20) |
| Unknown | 5 (20) |
N = 41. SUD, substance use disorder.